According to Kaiser Health News (KHN),1 the COVID-19 pandemic has been a real boon to Pfizer. Not only has it yielded “outsize benefits” in terms of profits, but it has also “given the drugmaker unusual weight in determining U.S. health policy.” “Based on internal research, the company’s executives have frequently announced the next stage in… Read More »
In a news release quietly published June 29, 2022, the U.S. Department of Health and Human Services announced that it, in partnership with the Department of Defense, agreed to purchase another 105 million doses of Pfizer’s COVID-19 shot — for $ 3.2 billion.1 The contract is intended to supply shots for a coming fall injection… Read More »
Breadcrumb Trail Links News Health Canada While health authorities are reassuring Canadians that it’s safe to mix COVID-19 vaccines doses, some appear to be rejecting Moderna for Pfizer Author of the article: Sharon Kirkey Publishing date: Jun 24, 2021 • 5 days ago • 5 minute read • 126 Comments “There may be some brand recognition… Read More »
A Hawaii man participating in a Pfizer-led study looking at third doses of its COVID-19 vaccine as booster shots said he joined the trial to help others, according to a local report. Gary Lahens of Honolulu took part in the company’s vaccine trials for the safety of his family and community, he told news outlet KHON2. He rolled his sleeve before the cameras to show the… Read More »